Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Comparative Cross Sectional

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Active Not Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07055074Active Not RecruitingPrimary

Evaluation of Hemodynamic Changes Using Different IAP for LC Under General Anesthesia

NCT07049380Active Not RecruitingPrimary

Post-Operative Analgesic Effect of Tramadol and Nalbuphine in Smoker and Non-Smoker Patients in LC

NCT04329143Not ApplicableCompletedPrimary

Post-Cholecystectomy Gall Bladder Remnant and Cystic Duct Stump Stone

Showing all 3 trials

Research Network

Common Treatments

  • Comparative Cross Sectional1
  • Open Completion Cholecystectomy1
  • Lap Completion Cholecystectomy1
  • Medium Pressure Pneumoperitoneum1
  • Low Pressure Pneumoperitoneum1

Active Sponsors

  • Superior University2
  • Zagazig University1

Top Investigators

Activity Timeline